Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3076336 70 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Context: 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. Objective: To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. Design: An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. Setting: This was a multicenter retrospective study using information collected from 3 predominant centers. Patients: A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. Main Outcome Measures: Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. Results: The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. Conclusions: Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder. © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Pelletier, F.
Perrier, S.
Cayami, F.K.
Mirchi, A.
Saikali, S.
Tran, L.T.
Ulrick, N.
Guerrero, K.
Rampakakis, E.
Van Spaendonk, R.M.L.
Naidu, S.
Pohl, D.
Gibson, W.T.
Demos, M.
Goizet, C.
Tejera-Martin, I.
Potic, A.
Fogel, B.L.
Brais, B.
Sylvain, M.
Sébire, G.
Lourenço, C.M.
Bonkowsky, J.L.
Catsman-Berrevoets, C.
Pinto, P.S.
Tirupathi, S.
Strømme, P.
De Grauw, T.
Gieruszczak-Bialek, D.
Krägeloh-Mann, I.
Mierzewska, H.
Philippi, H.
Rankin, J.
Atik, T.
Banwell, B.
Benko, W.S.
Blaschek, A.
Bley, A.
Boltshauser, E.
Bratkovic, D.
Brozova, K.
Cimas, I.
Clough, C.
Corenblum, B.
Dinopoulos, A.
Dolan, G.
Faletra, F.
Fernandez, R.
Fletcher, J.
Garcia Garcia, M.E.
Gasparini, P.
Gburek-Augustat, J.
Gonzalez Moron, D.
Hamati, A.
Harting, I.
Hertzberg, C.
Hill, A.
Hobson, G.M.
Innes, A.M.
Kauffman, M.
Kirwin, S.M.
Kluger, G.
Kolditz, P.
Kotzaeridou, U.
La Piana, R.
Liston, E.
McClintock, W.
McEntagart, M.
McKenzie, F.
Melançon, S.
Misbahuddin, A.
Suri, M.
Monton, F.I.
Moutton, S.
Murphy, R.P.J.
Nickel, M.
Onay, H.
Orcesi, S.
Özklnay, F.
Patzer, S.
Pedro, H.
Pekic, S.
Pineda Marfa, M.
Pizzino, A.
Plecko, B.
Poll-The, B.T.
Popovic, V.
Rating, D.
Rioux, M.-F.
Rodriguez Espinosa, N.
Ronan, A.
Ostergaard, J.R.
Rossignol, E.
Sanchez-Carpintero, R.
Schossig, A.
Senbil, N.
Sønderberg Roos, L.K.
Stevens, C.A.
Synofzik, M.
Sztriha, L.
Tibussek, D.
Timmann, D.
Tonduti, D.
Van De Warrenburg, B.P.
Vázquez-López, M.
Venkateswaran, S.
Wasling, P.
Wassmer, E.
Webster, R.I.
Wiegand, G.
Yoon, G.
Rotteveel, J.
Schiffmann, R.
Van Der Knaap, M.S.
Vanderver, A.
Martos-Moreno, G.Á.
Polychronakos, C.
Wolf, N.I.
Bernard, G.
Περιοδικό:
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Εκδότης:
Endocrine Society
Τόμος:
106
Αριθμός / τεύχος:
2
Σελίδες:
E660-E674
Λέξεις-κλειδιά:
corticotropin; estradiol; follitropin; growth hormone; hydrocortisone; luteinizing hormone; prolactin; somatomedin C; testosterone; thyrotropin; DNA directed RNA polymerase; DNA directed RNA polymerase III; POLR1C protein, human; POLR3A protein, human; POLR3B protein, human, Article; body height; corticotropin blood level; cross-sectional study; descriptive research; disease classification; endocrine disease; estradiol blood level; female; follitropin blood level; gene; genetic analysis; genetic variability; genotype; growth disorder; growth hormone blood level; head circumference; human; leukodystrophy; luteinizing hormone blood level; major clinical study; male; multicenter study; phenotype; POLR3A gene; POLR3B gene; POLR3C gene; prolactin blood level; retrospective study; testosterone blood level; thyroid function; thyrotropin blood level; thyroxine blood level; adolescent; adult; biological variation; child; clinical trial; cohort analysis; complication; demyelinating disease; disorders of mitochondrial functions; endocrine disease; genetic heterogeneity; genetics; growth disorder; hypogonadism; infant; mutation; newborn; preschool child; young adult, Adolescent; Adult; Biological Variation, Population; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; DNA-Directed RNA Polymerases; Endocrine System Diseases; Female; Genetic Heterogeneity; Growth Disorders; Hereditary Central Nervous System Demyelinating Diseases; Humans; Hypogonadism; Infant; Infant, Newborn; Male; Mitochondrial Diseases; Mutation; Retrospective Studies; RNA Polymerase III; Young Adult
Επίσημο URL (Εκδότης):
DOI:
10.1210/clinem/dgaa700
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.